Allergan Aesthetics, an AbbVie company , announced a nationwide open casting call in search of the next Faces of Natrelle®, encouraging women who have ...

Regenerative Medicine MarketThe global regenerative medicine industry is experiencing unprecedented growth, with an estimated valuation of USD 13,385.6 million in 2023. The market is projected to ...

The adoption of telemedicine and remote monitoring technologies in ophthalmology to accelerate the market growth, says Fact.MR in its new market rese ...

Explore the Pharmaceutical market's evolution in oral macromolecular drug formulations, driven by a commitment to targeted and convenient biologics delivery. ROCKVILLE, MD, UNITED STATES, January 28, ...

In addition, it has a joint venture with Allergan, a leader in ophthalmology ... investment of 33.33% in Yapan Bio that operates in the biologics/ bio-therapeutics and vaccine segments.

A whistleblower accusing Allergan Inc. of engaging in a kickback scheme to increase purchases of “Lap-Band’ obesity devices can advance a portion of his suit toward trial, a Maryland federal judge ...

10:30 a.m. ET Despite challenges in the CDMO industry, Samsung Biologics is "well positioned to kick-start a new phase of growth in 2025," CEO John Rim said in a press release ahead of his Tuesday ...

The FDA has accepted Eisai and Biogen’s biologics license application for a monthly infusion of IV Leqembi to treat individuals with mild cognitive impairment or mild dementia consistent with ...

Samsung Biologics has kicked off the start of 2025 with the largest single contract in the company's history, signing a record-breaking $1.41 billion deal, amounting to some 40 percent of the ...

AbbVie strives to have a remarkable impact on people’s lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in AbbVie’s Allergan ...